XLO - Xilio Therapeutics Inc Price Chart

Corporate company logo of Xilio Therapeutics Inc (XLO)

Xilio Therapeutics, Inc. (XLO) management demonstrates high scientific expertise and testing transparency, leveraging a strategic alliance with Gilead and sufficient capital. The business is based on the development of targeted oncology drugs, where low synthesis costs following certification guarantee high margins. The price trend captured at 7.78 complements the picture. The partnership with the pharma behemoth improves current cash flow while awaiting the completion of final molecule validations.

Market Price: Xilio Therapeutics, Inc. (XLO) for 07/04/2022 - 11/17/2026

Analytical breakdowns for Xilio Therapeutics, Inc.

- current price and projected stock value:
- market capitalization statistics:
Summary company analytics:Xilio Therapeutics, Inc.
Brand item of Xilio Therapeutics, Inc.

The lack of in-house manufacturing and reliance on CDMO partners make Xilio Therapeutics, Inc. (XLO) dependent on external contractors, which is reflected in the volatility of its market quotes. By analyzing the price action, an investor determines historical price boundaries where extremes serve as indicators of the asset being overbought or undervalued, allowing for a correlation between current acquisition costs and the fundamental risks of stagnation or growth potential.

Competitors of Xilio Therapeutics, Inc.

Price Chart BeiGene Oncology (ONC)|HALO (Halozyme) - Price Performance Chart|RevMed - Stock Quotes|Stock Price Ascentage Pharma Corp AAPG|CGON - Price Chart|Price Rate Chart urogen.com (URGN)|BCAX (Bicara Bio) - Stock Quotes|PSNL (Personalis) - Price Chart|ERAS (Erasca Oncology) - Stock Price|Stock Quotes Delcath (DCTH)|Stock Price YMAB|Stock Price aurabiosciences.com (AURA)|Price Chart candeltx.com CADL|ARAY: Share Price|SELLAS Life Sciences Group Inc. - Stock Price|Actuate Therapeutics, Inc (ACTU) - Stock Quotes|CTOR: Stock Price|Market Price TuHURA (HURA)|Price Chart Protara Therapeutics, Inc.|FATE: Price Performance Chart|Stock Quotes WHWK (Aadi Bioscience, Inc.)|TCRX (TScan Therapeutics, Inc.) - Price Performance Chart|Stock Price CSBR (Champions Oncology)|XBIT - Stock Quotes|CVM - Price Chart|OSTX - Stock Price|Radiopharm Theranostics Limited (RADX) - Price Chart|Artiva Biotherapeutics Inc. - Price Performance Chart|ANL (Adlai Nortye Limited) - Stock Price|Market Price Veru VERU|Stock Quotes TPST (Tempest Therapeutics)|RENB (Renovaro) - Price Performance Chart|Mural Oncology PLC - Stock Quotes|Stock Price Kairos Pharma Inc KAPA|OKUR - Price Chart|CytoMed Therapeutics Limited - Price|CRIS: Stock Price|APLM (Apollomics Corp) - Price Chart|THAR (Tharimmune Corporation) - Stock Price|Share Price ADVB (Advanced Biomed Inc)|Stock Price GNPX|Market Chart Calidi Bio|Price Chart Sunshine Biopharma, Inc. SBFM|XBIO - Stock Quotes|SLRX - Price Chart|PPBT: Price Chart|AONC (AON) - Stock Quotes|BGNE (BeiGene) - Price Chart|Stock Quotes CKPT|ELEV: Price Performance Chart|Stock Price ICAD|Price Chart IKNA (Ikena Oncology Inc.)|Price Chart notablelabs.com NTBL|Price Performance Chart VIRX|MOR - Price Chart|NAYA (NAYA Biosciences Inc.) - Share Price|AAPGV: Stock Price